Twenty-four patients with breast carcinoma refractory to successive hormonal treatment, CMF (cyclophosphamide, methotrexate, and 5-FU) or its modifications, and AV (doxorubicin and vincristine) were treated iv with 3 mg/m2 of vinblastine, 4 mg/m2 of mitomycin, and 50 mg/m2 of carmustine (BCNU) administered simultaneously every 14 days. This regimen was of little benefit in the 22 evaluable patients, yielding a 9% response rate.
|Number of pages||3|
|Journal||Cancer Treatment Reports|
|Publication status||Published - 1982|
ASJC Scopus subject areas
- Cancer Research